Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
The American Journal of Surgical Pathology|October 20, 1998
Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 casesB Vergier, M Beylot-Barry, K Pulford, et al.
The British Journal of Dermatology|February 3, 2016
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB-IVA mycosis fungoides/Sézary syndromeF Child, P L Ortiz-Romero, R Alvarez, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomasE Toulemonde, S Chevret, M Battistella, et al.
Clinical and Experimental Dermatology|May 14, 2021
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study GroupC Bergqvist, M Beylot-Barry, C Ram-Wolff, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2014
Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literatureS Ingen-Housz-Oro, N Franck, N Beneton, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2012
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithmZ Reguiai, J B Bachet, C Bachmeyer, et al.
Blood|March 25, 2000
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious LymphomasB Vergier, A de Muret, M Beylot-Barry, et al.
International Journal of Cancer|June 22, 2000
Delays in diagnosis and melanoma prognosis (I): the role of patientsM A Richard, J J Grob, M F Avril, et al.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 14, 2017
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohortE Sbidian, C Giboin, H Bachelez, et al.
Pageof 16